M3258

CAS: 2285330-15-4 货号: M655908 分子式: C17H20BNO5 分子量: 329.16 PubChem CID: 138319683
有货
级别和纯度: 10mM in DMSO
储存条件
-80℃储存
运输条件
特低温运输
★
规格
库存
价格
数量
1ml
M655908-1ml
期货 Stock Image
¥3,548.90
请输入您要添加的产品数量

概述


M3258 is an orally bioavailable, potent, reversible and highly selective immunoproteasome subunit LMP7 (β5i) inhibitor. M3258 exerts high biochemical ( IC 50 =3.6 nM) and cellular ( IC 50 =3.4 nM) potency against the LMP7 subunit. M3258 shows strong antitumor efficacy in multiple myeloma xenograft models. M3258 leads to a significant and prolonged suppression of tumor LMP7 activity and ubiquitinated protein turnover and the induction of apoptosis in multiple myeloma cells

In Vitro

M3258 inhibits human LMP7 with a mean IC 50 of 4.1 nM. M3258 displays weak activity against the constitutive proteasome subunit β5 (mean IC 50 =2519 nM). M3258 potently inhibits LMP7 in the human multiple myeloma cell lines MM.1S and U266B1 and in human, rat, and dog PBMCs with IC 50 s between 2 and 37 nM. M3258 induces a >four fold accumulation of ubiquitinated proteins with an EC 50 of 1980 nM in MM.1S cells. M3258 interferes with immunoproteasome function. M3258 also induces apoptosis assessed by caspase 3/7 activity (EC 50 =420 nM;>3.5-fold induction) and reduces MM.1S cell viability (IC 50 =367 nM). MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Viability AssayCell Line: MM.1S cells Concentration: 0.01-100 nM Incubation Time: 2 hours Result: Potently inhibited LMP7 in the human multiple myeloma cell lines MM.1S (IC 50 =2.2 nM).

In Vivo

M3258 (1 mg/kg; 10 mg/kg) shows superior antitumor efficacy in selected multiple myeloma and mantle cell lymphoma xenograft models compared with the approved nonselective proteasome inhibitors bortezomib and ixazomib. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Female H2d Rag2 mice or female CB-17 SCID mice (U266B1 subcutaneous xenograft model; MM.1S subcutaneous xenograft model)Dosage: 1 mg/kg in U266B1 subcutaneous xenograft model; 10 mg/kg in MM.1S subcutaneous xenograft model Administration: P.o.; either once daily, every 2 days or twice weekly (days 1 and 4) Result: Displayed significant and strong antitumor efficacy.

IC50& Target:LMP7

规格

规格或纯度
10mM in DMSO
英文名称
M3258
生化机理
M3258 是一种口服生物利用型、强效、可逆和高选择性免疫蛋白酶体亚基 LMP7(β5i)抑制剂。 M3258 对 LMP7 亚基具有很高的生化效力(IC 50 =3.6 nM)和细胞效力(IC 50 =3.4 nM)。M3258 对 LMP7 亚基具有很强的抗
储存条件
-80℃储存
运输条件
特低温运输
名称和识别符
分子类型
小分子
Isomeric SMILES
B([C@H](CC1=COC2=CC=CC=C21)NC(=O)[C@@H]3C[C@H]4CC[C@@H]3O4)(O)O
PubChem CID
MeSH Entry Terms
((1R)-2-(1-benzofuran-3-yl)-1-(((1S,2R,4R)-7-oxabicyclo(2.2.1)heptane-2-carbonyl)amino)ethyl)boronic acid;M3258
分子量
329.16

高级数据

质检证书(CoA,COO,BSE/TSE 和分析图谱)
C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:
溶液计算器

常见问题

本产品应如何储存?
请于?80 °C条件下保存。需超低温保存以维持规定的有效期。
本产品如何运输?
本产品采用干冰配冷袋冷冻运输。收货后请立即拆包,并按上述储存条件保存;处理干冰时请戴隔热手套并保持通风。
本产品的 CAS 号、分子式和分子量是多少?
本产品的 CAS 号为 2285330-15-4,分子式为 C17H20BNO5,分子量为 329.16 g/mol。
如何获取批次专用COA?
每个订单都会随附分析证书(COA),您也可以从账户订单历史中下载。如需订购前的COA,请联系您的客户代表,或使用PDP上的"申请COA"按钮——我们将提供代表性批次的COA。